Article information
Full text is only aviable in PDF
Bibliografía
[1.]
K.F. Rabe, S. Hurd, A. Anzueto, P.J. Barnes, S.A. Buist, A.P. Calverley, et al.
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
Am J Respir Crit Care Med, 176 (2007), pp. 532-555
[2.]
G. Peces-Barba, J.A. Barberá, A. Agustí, C. Casanova, A. Casas, J. Izquierdo, et al.
Guía clínica de diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica.
SEPAR-ALAT, (2007),
[3.]
A.D. López, C.D. Mathers, M. Ezzati, D.T. Jamison, C.J. Murray.
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data.
Lancet, 367 (2006), pp. 1747-1757
[4.]
A.D. López, C.C. Murray.
The global burden of disease, 1990-2020.
Nat Med, 4 (1998), pp. 1241-1243
[5.]
A. Agustí, A. Thomas.
Neff lecture. Chronic obstructive pulmonary disease: a systemic disease.
Proc Am Thorac Soc, 3 (2006), pp. 478-481
[6.]
M.K. Han, A. Agustí, P.M. Calverley, B.R. Celli, G. Criner, J.L. Curtis.
Chronic obstructive pulmonary disease phenotypes: the future of COPD.
Am J Respir Crit Care Med, 182 (2010), pp. 598-604
[7.]
Agustí A, Sobradillo P, Celli B. Addressing the complexity of COPD: from phenotypes and biomarkers to scale-free networks, systems biology and P4 medicine. Am J Respir Crit Care Med. 2010. En prensa.
[8.]
J.R. Hurst, J. Vestbo, A. Anzueto, N. Locantore, H. Mullerova, R. Tal-Singer, et al.
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease.
N Engl J Med, 363 (2010), pp. 1128-1138
[9.]
P.J. Barnes, B.R. Celli.
Systemic manifestations and comorbidities of COPD.
Eur Respir J, 33 (2009), pp. 1165-1185
Copyright © 2010. Sociedad Española de Neumología y Cirugía Torácica
